Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Schleussner N"'
Autor:
Wirsik NM; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany., Appel PC; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Braun A; Department of Radiology, University Hospital Heidelberg, Heidelberg, Germany., Strowitzki MJ; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Schleussner N; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Nienhüser H; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Schneider M; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Schmidt T; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany. Electronic address: Thomas.Schmidt1@uk-koeln.de.
Publikováno v:
The Journal of surgical research [J Surg Res] 2024 Jun; Vol. 298, pp. 176-184. Date of Electronic Publication: 2024 Apr 14.
Autor:
Wirsik NM; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Cologne, Cologne, Germany., Chen M; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., He L; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Yasar U; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Gaukel J; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Quaas A; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Nienhüser H; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Leugner E; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Yuan S; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Schleussner N; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Cologne, Cologne, Germany., Jung JO; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Cologne, Cologne, Germany., Plücker JS; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Schneider M; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Schmidt T; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Cologne, Cologne, Germany.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (7), pp. e6866.
Autor:
Wirsik NM; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany., Stengel S; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Jung JO; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany., Sisic L; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Crnovrsanin N; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Nienhüser H; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Schleussner N; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Hamm A; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Büchler MW; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany., Schmidt T; Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany.; Department of General, Visceral, Cancer and Transplant Surgery, University Hospital of Cologne, Cologne, Germany.
Publikováno v:
The British journal of surgery [Br J Surg] 2024 Jan 03; Vol. 111 (1).
Autor:
Schleussner N; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Cauchy P; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; University Medical Center Freiburg, 79106, Freiburg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Franke V; Bioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max-Delbrück-Center, Berlin, Germany., Giefing M; Institute of Human Genetics, Polish Academy of Sciences, Poznan, 60-479, Poland.; Institute of Human Genetics, Christian-Albrechts-University Kiel, 24105, Kiel, Germany., Fornes O; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada., Vankadari N; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC, 3000, Australia., Assi SA; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Costanza M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Weniger MA; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, 45122, Essen, Germany., Akalin A; Bioinformatics and Omics Data Science Platform, Berlin Institute for Medical Systems Biology, Max-Delbrück-Center, Berlin, Germany., Anagnostopoulos I; Institute of Pathology, Universität Würzburg and Comprehensive Cancer Centre Mainfranken (CCCMF), Würzburg, Germany., Bukur T; TRON gGmbH - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany., Casarotto MG; Research School of Biology, The Australian National University, Canberra, ACT, Australia., Damm F; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany., Daumke O; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Structural Biology, 13125, Berlin, Germany., Edginton-White B; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Gebhardt JCM; Department of Physics, Institute of Biophysics, Ulm University, Ulm, Germany., Grau M; Department of Physics, University of Marburg, 35052, Marburg, Germany.; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Grunwald S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Structural Biology, 13125, Berlin, Germany., Hansmann ML; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute for Pharmacology and Toxicology, Goethe University, Frankfurt am Main, Germany., Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany., Huber L; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany., Kärgel E; Signal Transduction in Tumor Cells, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Lusatis S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Noerenberg D; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany., Obier N; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany.; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Pannicke U; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany., Fischer A; Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany., Reisser A; Department of Physics, Institute of Biophysics, Ulm University, Ulm, Germany., Rosenwald A; Institute of Pathology, Universität Würzburg and Comprehensive Cancer Centre Mainfranken (CCCMF), Würzburg, Germany., Schwarz K; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany.; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, Ulm, Germany., Sundararaj S; Research School of Biology, The Australian National University, Canberra, ACT, Australia., Weilemann A; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Winkler W; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Xu W; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Lenz G; Medical Department A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Rajewsky K; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Immune Regulation and Cancer, 13125, Berlin, Germany., Wasserman WW; Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada., Cockerill PN; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Scheidereit C; Signal Transduction in Tumor Cells, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Siebert R; Institute of Human Genetics, Christian-Albrechts-University Kiel, 24105, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, 89081, Ulm, Germany., Küppers R; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, 45122, Essen, Germany., Grosschedl R; Max Planck Institute of Immunobiology and Epigenetics, 79108, Freiburg, Germany., Janz M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany., Bonifer C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Mathas S; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, 13125, Berlin, Germany. stephan.mathas@charite.de.; Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, 10117, Berlin, Germany. stephan.mathas@charite.de.; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany. stephan.mathas@charite.de.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. stephan.mathas@charite.de.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 07; Vol. 14 (1), pp. 6947. Date of Electronic Publication: 2023 Nov 07.
Autor:
Lopez C; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081, Germany; Institute of Human Genetics, Christian-Albrechts-University, Kiel, 24105., Schleussner N; Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, 13125, Germany; Hematology, Oncology and Tumor Immunology, Charite - Universitatsmedizin Berlin, Berlin, 12200, Germany, and Experimental and Clinical Research Center, a joint cooperation between the MDC and the Charite, Berlin, 13125., Bernhart SH; Interdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, 04107, Germany; Bioinformatics Group, Department of Computer, University of Leipzig, Leipzig, 04107, Germany; Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, 04107., Kleinheinz K; Department for Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, 69120., Sungalee S; EMBL Heidelberg, Genome Biology Unit, Heidelberg, 69117., Sczakiel HL; Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, 13125, Germany; Hematology, Oncology and Tumor Immunology, Charite - Universitatsmedizin Berlin, Berlin, 12200, Germany, and Experimental and Clinical Research Center, a joint cooperation between the MDC and the Charite, Berlin, 13125., Kretzmer H; Interdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, 04107, Germany; Bioinformatics Group, Department of Computer, University of Leipzig, Leipzig, 04107, Germany; Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, 04107, Germany; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin., Toprak UH; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, 69120, Germany; Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ), Division of Neuroblastoma Genomics (B087, German Cancer Research Center (DKFZ), Heidelberg, 69120., Glaser S; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081., Wagener R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081, Germany; Institute of Human Genetics, Christian-Albrechts-University, Kiel, 24105., Ammerpohl O; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081, Germany; Institute of Human Genetics, Christian-Albrechts-University, Kiel, 24105., Bens S; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081, Germany; Institute of Human Genetics, Christian-Albrechts-University, Kiel, 24105., Giefing M; Institute of Human Genetics, Christian-Albrechts-University, Kiel, 24105, Germany; Institute of Human Genetics, Polish Academy of Sciences, Poznan, 60-479, Poland., Sanchez JCG; BioQuant and Biochemie Zentrum Heidelberg (BZH), Heidelberg University, Heidelberg, 69120., Apic G; BioQuant and Biochemie Zentrum Heidelberg (BZH), Heidelberg University, Heidelberg, 69120., Hubschmann D; German Cancer Consortium (DKTK), Heidelberg, 69120, Germany; Heidelberg Institute of Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, 69120, Germany; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, 69120., Janz M; Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, 13125, Germany; Hematology, Oncology and Tumor Immunology, Charite - Universitatsmedizin Berlin, Berlin, 12200, Germany, and Experimental and Clinical Research Center, a joint cooperation between the MDC and the Charite, Berlin, 13125., Kreuz M; Institute for Medical Informatics Statistics and Epidemiology, Leipzig, 04107., Mottok A; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081., Muller JM; Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Albert-Ludwigs-Universitat Freiburg, Freiburg, 79104., Seufert J; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, 69120., Hoffmann S; Interdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, 04107, Germany; Bioinformatics Group, Department of Computer, University of Leipzig, Leipzig, 04107, Germany; Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, 04107, Germany; Leibniz Institute on Ageing-Fritz Lipmann Institute (FLI), Computational Biology, Jena, 07745., Korbel JO; EMBL Heidelberg, Genome Biology Unit, Heidelberg, 69117., Russell RB; BioQuant and Biochemie Zentrum Heidelberg (BZH), Heidelberg University, Heidelberg, 69120., Schule R; Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Albert-Ludwigs-Universitat Freiburg, Freiburg, 79104, Germany; BIOSS Centre of Biological Signalling Studies, Albert-Ludwigs-University Freiburg, Freiburg, 79104., Trumper L; Department of Hematology and Oncology, Georg-August-University of Gottingen, Gottingen, 37075., Klapper W; Hematopathology Section, Christian-Albrechts-University, Kiel, 24105., Radlwimmer B; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120, Heidelberg., Lichter P; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120, Heidelberg., Kuppers R; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, 45147, Germany, and German Cancer Consortium (DKTK)., Schlesner M; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany; Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, Augsburg, 86159., Mathas S; Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, 13125, Germany; Hematology, Oncology and Tumor Immunology, Charite - Universitatsmedizin Berlin, Berlin, 12200, Germany, and Experimental and Clinical Research Center, a joint cooperation between the MDC and the Charite, Berlin, 13125., Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, 89081, Germany; Institute of Human Genetics, Christian-Albrechts-University, Kiel, 24105.
Publikováno v:
Haematologica [Haematologica] 2023 Feb 01; Vol. 108 (2), pp. 543-554. Date of Electronic Publication: 2023 Feb 01.
Autor:
Fornes O, Jia A, Kuehn HS, Min Q, Pannicke U, Schleussner N, Thouenon R, Yu Z, de Los Angeles Astbury M, Biggs CM, Galicchio M, Garcia-Campos JA, Gismondi S, Gonzalez Villarreal G, Hildebrand KJ, Hönig M, Hou J, Moshous D, Pittaluga S, Qian X, Rozmus J, Schulz AS, Staines-Boone AT, Sun B, Sun J, Uwe S, Venegas-Montoya E, Wang W, Wang X, Ying W, Zhai X, Zhou Q, Akalin A, André I, Barth TFE, Baumann B, Brüstle A, Burgio G, Bustamante JC, Casanova JL, Casarotto MG, Cavazzana M, Chentout L, Cockburn IA, Costanza M, Cui C, Daumke O, Del Bel KL, Eibel H, Feng X, Franke V, Gebhardt JCM, Götz A, Grunwald S, Hoareau B, Hughes TR, Jacobsen EM, Janz M, Jolma A, Lagresle-Peyrou C, Lai N, Li Y, Lin S, Lu HY, Lugo-Reyes SO, Meng X, Möller P, Moreno-Corona N, Niemela JE, Novakovsky G, Perez-Caraballo JJ, Picard C, Poggi L, Puig-Lombardi ME, Randall KL, Reisser A, Schmitt Y, Seneviratne S, Sharma M, Stoddard J, Sundararaj S, Sutton H, Tran LQ, Wang Y, Wasserman WW, Wen Z, Winkler W, Xiong E, Yang AWH, Yu M, Zhang L, Zhang H, Zhao Q, Zhen X, Enders A, Kracker S, Martinez-Barricarte R, Mathas S, Rosenzweig SD, Schwarz K, Turvey SE, Wang JY
Publikováno v:
Science immunology [Sci Immunol] 2023 Jan 20; Vol. 8 (79), pp. eade7953. Date of Electronic Publication: 2023 Jan 20.
Autor:
von Hoff, L., Kärgel, E., Franke, V., McShane, E., Schulz-Beiss, K.W., Patone, G., Schleussner, N., Kolesnichenko, M., Hübner, N., Daumke, O., Selbach, M., Akalin, A., Mathas, S., Scheidereit, C.
Persistent NF-κB activation is a hallmark of the malignant Hodgkin/Reed-Sternberg (HRS) cells in classical Hodgkin lymphoma (cHL). Genomic lesions, Epstein-Barr virus infection, soluble factors and tumor-microenvironment interactions contribute to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::e96a78198bbb18fdc235b48f96842686
http://edoc.mdc-berlin.de/18026/7/18026suppl.zip
http://edoc.mdc-berlin.de/18026/7/18026suppl.zip
Autor:
Vaquero-Siguero N; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Schleussner N; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg University, 69120 Heidelberg, Germany., Volk J; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.; Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany., Mastel M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Meier J; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany., Jackstadt R; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany.; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 31; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 31.
Autor:
Weisshaar N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Wu J; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Ming Y; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Madi A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Hotz-Wagenblatt A; Core Facility Omics IT and Data Management, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Ma S; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Mieg A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Hering M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Zettl F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Mohr K; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Schlimbach T; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Ten Bosch N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hertel F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Müller L; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Byren H; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Wang M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Borgers H; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Munz M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Schmitt L; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., van der Hoeven F; Transgenic Service (W450), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Kloz U; Transgenic Service (W450), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Carretero R; DKFZ-Bayer Immunotherapeutic Lab, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Schleußner N; Cancer Progression and Metastasis (A013), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, 69120 Heidelberg, Germany., Jackstadt RF; Cancer Progression and Metastasis (A013), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hofmann I; Division of Vascular Oncology and Metastasis (A190), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Core Facility Antibodies (W170), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Cui G; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), 55131 Mainz, Germany.
Publikováno v:
Science immunology [Sci Immunol] 2022 May 27; Vol. 7 (71), pp. eabh1873. Date of Electronic Publication: 2022 May 27.
Autor:
Wurster KD; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany., Costanza M; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany., Kreher S; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany., Glaser S; Institute of Human Genetics, Ulm University, Ulm University Medical Center, 89081 Ulm, Germany., Lamprecht B; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Schleussner N; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany., Anagnostopoulos I; Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany., Hummel M; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany., Jöhrens K; Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany., Stein H; Pathodiagnostik Berlin, 12099 Berlin, Germany., Molina A; Sutro Biopharma, South San Francisco, CA 94080, USA., Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands., Gillissen B; Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, 13125 Berlin, Germany., Köchert K; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany., Siebert R; Institute of Human Genetics, Ulm University, Ulm University Medical Center, 89081 Ulm, Germany., Merkel O; Unit of Experimental and Laboratory Animal Pathology, Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.; European Research Initiative on ALK-related malignancies (ERIA), 1090 Vienna, Austria., Kenner L; Unit of Experimental and Laboratory Animal Pathology, Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.; European Research Initiative on ALK-related malignancies (ERIA), 1090 Vienna, Austria., Janz M; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany., Mathas S; Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.; Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; European Research Initiative on ALK-related malignancies (ERIA), 1090 Vienna, Austria.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Oct 07; Vol. 13 (19). Date of Electronic Publication: 2021 Oct 07.